Form 424B3 Estrella Immunopharma,
Tweet
Share
E-mailhttp://archive.fast-edgar.com/20260213/AV2JJ22CLC22NT2V222M2ZY2N35TZ222Z282
Filed on: February 13, 2026
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Estrella adds Oregon Health & Science University to lymphoma trial
- ExxonMobil in Mozambique Awards McDermott Letter of Intent for Rovuma LNG Project
- Claude and Microsoft 365 Copilot AI Agents Named Champions in Info-Tech Research Group's 2026 Agentic AI Platforms Data Quadrant
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
